Home > Insider Trading > Filing (0001209191-14-004558)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197036	I Bruce Sachs	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-01-22	5,800	$83.89	40,710	No	4	S	Direct
Common Stock	Disposition	2014-01-22	600	$84.90	40,110	No	4	S	Direct
Common Stock	Disposition	2014-01-22	1,500	$85.87	38,610	No	4	S	Direct
Common Stock	Disposition	2014-01-22	400	$86.91	38,210	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $83.89 (range $83.46 to $84.37).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $84.90 (range $84.47 to $85.45).
Open market sales reported on this line occurred at a weighted average price of $85.87 (range $85.50 to $86.47).
Open market sales reported on this line occurred at a weighted average price of $86.91 (range $86.53 to $87.43).